MYT1L is a conserved zinc finger transcription factor and mutations have been reported in patients diagnosed with intellectual disability, schizophrenia, epilepsy, and ASD [13–18], suggesting that MYT1L-mediated gene regulation may be important in preventing NDDs including ASD. The gene discussed is MYT1L; the disease is epilepsy.